Brain Stimulation + Physical Therapy for Parkinson's Disease
Trial Summary
Will I have to stop taking my current medications?
The trial requires that participants have been taking stable medications for Parkinson's disease for at least 30 days, so you will not need to stop your current medications.
What data supports the effectiveness of the treatment Brain Stimulation + Physical Therapy for Parkinson's Disease?
Research shows that combining transcranial direct current stimulation (tDCS) with physical therapy can improve walking ability in Parkinson's patients. Additionally, physical therapy alone has been shown to enhance motor performance and functional abilities in these patients, suggesting that it is a valuable part of comprehensive treatment.12345
Is brain stimulation combined with physical therapy safe for humans?
Transcranial direct current stimulation (tDCS) is generally considered safe when used within standardized protocols in research or clinical settings. It has been studied in both healthy individuals and those with various brain disorders, showing potential as a safe complementary treatment, especially when combined with other therapies like physical therapy.36789
How does the treatment of brain stimulation and physical therapy for Parkinson's disease differ from other treatments?
This treatment combines non-invasive brain stimulation techniques, like transcranial direct current stimulation (tDCS) and transcranial ultrasound stimulation (TUS), with physical therapy to enhance motor function and potentially offer neuroprotective benefits. Unlike traditional drug therapies, this approach focuses on improving neural reorganization and recovery through physical and brain stimulation, which may provide longer-lasting improvements in motor abilities.14101112
What is the purpose of this trial?
This trial aims to understand the mechanism and to test whether transcranial direct current stimulation (tDCS) combined with transcranial ultrasound (TUS) (tDCS+TUS) combined with physical therapy (PT) will induce significant therapeutic effects in postural instability in Parkinson's disease (PT) patients. The investigators designed a double-blinded, placebo controlled, randomized study to investigate the effects of 2 weeks of TDCS+TUS on postural instability in PD patients receiving PT. (Followed by biweekly sessions for 2 more weeks in Phase II)
Research Team
Felipe Fregni, MD, PhD, MPH
Principal Investigator
Spaulding Rehabilitation Hospital
Eligibility Criteria
This trial is for people aged 40-90 with Parkinson's Disease who have balance issues or postural instability and are on stable PD medications. Excluded are those with other balance-affecting conditions, brain surgeries, metal in the head, severe medical problems, pregnancy, recent PT programs, non-PD parkinsonism syndromes, certain psychiatric or substance abuse histories.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment Phase I
Participants receive tDCS+TUS combined with physical therapy for 2 weeks
Treatment Phase II
Biweekly sessions of tDCS+TUS combined with physical therapy for an additional 2 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Active tDCS and Active TUS
- Physical Therapy
- Sham TDCS and Sham TUS
Find a Clinic Near You
Who Is Running the Clinical Trial?
Spaulding Rehabilitation Hospital
Lead Sponsor
Highland Instruments, Inc.
Industry Sponsor